BRIEF published on 12/17/2025 at 17:50, 8 months 30 days ago Accor Adjusts Timing of Share Buyback Program Launch Accor Regulatory Compliance Share Buyback Essendi Insider Information
REGULATED PRESS RELEASE published on 12/17/2025 at 17:45, 8 months 30 days ago Adjustment in the timing of the launch of a new share buyback program Accor postpones €100 million share buyback program launch from Q4 2025 to Q1 2026 due to insider information on Essendi stake disposal progress Accor Share Buyback Postpone Essendi Insider Information
BRIEF published on 12/03/2025 at 10:44, 9 months 13 days ago Accor's Updated Share Capital and Voting Rights Share Capital Voting Rights French Commercial Code Accor December 2025
REGULATED PRESS RELEASE published on 12/03/2025 at 10:39, 9 months 13 days ago Disclosure of shares outstanding and voting rights - 03.12.2025 Accor discloses share capital & voting rights as of November 30, 2025 as per French Commercial Code. For more info, visit https://group.accor.com/en Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 11/04/2025 at 16:05, 10 months 12 days ago Accor's Share Capital and Voting Rights Update Share Capital Voting Rights Accor Disclosure November 2025
REGULATED PRESS RELEASE published on 11/04/2025 at 16:00, 10 months 12 days ago Disclosure of shares outstanding and voting rights - 04.11.2025 Accor discloses share capital and voting rights for October 31, 2025, in accordance with French Commercial Code. Total potential and exercisable voting rights provided Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 10/03/2025 at 09:05, 11 months 14 days ago Accor's September 2025 Share Capital and Voting Rights Information Share Capital Voting Rights French Commercial Code Accor September 2025
REGULATED PRESS RELEASE published on 10/03/2025 at 09:00, 11 months 14 days ago Disclosure of shares outstanding and voting rights - 03.10.2025 Accor discloses Share Capital and Voting Rights as of September 30, 2025, in accordance with French Commercial Code. Total potential voting rights: 285,067,005 Exercisable voting rights: 274,182,613 Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 09/30/2025 at 18:50, 11 months 16 days ago Accor Completes Second Tranche of Share Buyback Programme Shareholders Investors Accor Share Buyback Stock Market
REGULATED PRESS RELEASE published on 09/30/2025 at 18:45, 11 months 16 days ago Completion of the second tranche of the share buyback programme Accor completes second tranche of EUR240m share buyback program acquiring 5,666,436 shares at €42.35 average price. Part of €440m program announced on February 20th, 2025 Accor Investor Relations Share Buyback Program Tranche Completion EUR240m
Published on 09/16/2026 at 23:45, 9 hours 46 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 12 hours 1 minute ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 16 hours 36 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 18 hours 31 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 19 hours 31 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 09:28, 3 minutes ago KNDS THL20 TURRETS SELECTED FOR INDIA’S NEW LIGHT COMBAT HELICOPTER PROGRAM
Published on 09/17/2026 at 09:00, 31 minutes ago Encavis completes EUR 282 million non-recourse project financing for 351 MW solar PV portfolio in Italy
Published on 09/17/2026 at 09:00, 31 minutes ago Grünenthal announces pricing of €850 million of bonds
Published on 09/16/2026 at 17:45, 15 hours 46 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 2 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 15 hours ago Report on the Combined General Meeting of the 10th of September 2026
